Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes

Diabetes, Obesity and Metabolism

Volumn 11, Issue 7, 2009, Pages 721-728

  McAinch, A J ^a   Cameron Smith, D ^b  

^a VICTORIA UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

AMPK; Diabetes; Fat metabolism; MRNA; Muscle; Obesity

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADIPONECTIN; CYCLIC GMP; CYCLOPHILIN; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT 3; CYTOCHROME C OXIDASE SUBUNIT 4; FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOGENESIS; BIOPSY; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID OXIDATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEAN BODY WEIGHT; MALE; MITOCHONDRIAL GENE; MYOTUBE; NUCLEOTIDE SEQUENCE; OBESITY; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE;

EID: 70449495895     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01042.x     Document Type: Article

References (42)

1. Astrup A, Buemann B, Christensen N, Toubro S. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol Endocrinol Metab 1994, 266:E592-E599.
2. Ouchi N, Kihara S, Arita Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
3. Weyer C, Funahashi T, Tanaka S. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
4. Ryan AS, Berman DM, Nicklas BJ. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003, 26:2383-2388.
5. Bluher M, Bullen JW, Lee JH. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 2006, 91:2310-2316.
6. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 2004, 27:629-630.
7. Yang WS, Lee WJ, Funahashi T. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86:3815-3819.
8. Yamauchi T, Kamon J, Minokoshi Y. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
9. Saha AK, Schwarsin AJ, Roduit R. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem 2000, 275:24279-24283.
10. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48:1667-1671.
11. McAinch AJ, Steinberg GR, Mollica J. Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals. Obesity 2006, 14:1898-1904.
12. Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT. Increase of adiponectin receptor gene expression by physical exercise in soleus muscle of obese Zucker rats. Eur J Appl Physiol 2006, 97:189-195.
13. Yamauchi T, Kamon J, Ito Y. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
14. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 2006, 55:2562-2570.
15. Chen MB, McAinch AJ, Macaulay SL. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 2005, 90:3665-3672.
16. Bruce CR, Mertz VA, Heigenhauser GJ, Dyck DJ. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 2005, 54:3154-3160.
17. Holness MJ, Kraus A, Harris RA, Sugden MC. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes 2000, 49:775-781.
18. Peters SJ, Harris RA, Heigenhauser GJ, Spriet LL. Muscle fiber type comparison of PDH kinase activity and isoform expression in fed and fasted rats. Am J Physiol Regul Integr Comp Physiol 2001, 280:R661-R668.
19. Tunstall RJ, Mehan KA, Hargreaves M, Spriet LL, Cameron-Smith D. Fasting activates the gene expression of UCP3 independent of genes necessary for lipid transport and oxidation in skeletal muscle. Biochem Biophys Res Commun 2002, 294:301-308.
20. Tunstall RJ, McAinch AJ, Hargreaves M, van Loon LJ, Cameron-Smith D. Reduced plasma free fatty acid availability during exercise: effect on gene expression. Eur J Appl Physiol 2007, 99:485-493.
21. Blau HM, Webster C. Isolation and characterization of human muscle cells. Proc Natl Acad Sci U S A 1981, 78:5623-5627.
22. Gaster M, Beck-Nielsen H, Schroder HD. Proliferation conditions for human satellite cells. The fractional content of satellite cells. Apmis 2001, 109:726-734.
23. McAinch AJ, Steinberg GR, Mollica J. Leptin stimulation of COXIV is impaired in obese skeletal muscle myotubes. Obes Res Clin Pract 2007, 1:53-60.
24. Steinberg GR, McAinch AJ, Chen MB. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 2006, 91:3592-3597.
25. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289.
26. Holness MJ, Sugden MC. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans 2003, 31:1143-1151.
27. Chokkalingam K, Jewell K, Norton L. High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: an important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin Endocrinol Metab 2007, 92:284-292.
28. Kim YI, Lee FN, Choi WS, Lee S, Youn JH. Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes 2006, 55:2311-2317.
29. Tsintzas K, Chokkalingam K, Jewell K, Norton L, Macdonald IA, Constantin-Teodosiu D. Elevated free fatty acids attenuate the insulin-induced suppression of PDK4 gene expression in human skeletal muscle: potential role of intramuscular long-chain acyl-coenzyme A. J Clin Endocrinol Metab 2007, 92:3967-3972.
30. Jeoung NH, Harris RA. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008, 295:E46-E54.
31. Tomas E, Tsao TS, Saha AK. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 2002, 99:16309-16313.
32. Lee FN, Zhang L, Zheng D, Choi WS, Youn JH. Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA. Am J Physiol Endocrinol Metab 2004, 287:E69-E74.
33. Furuyama T, Kitayama K, Yamashita H, Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscles during energy deprivation. Biochem J 2003, 375:365-371.
34. Tsuchida A, Yamauchi T, Ito Y. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004, 279:30817-30822.
35. Mao X, Kikani CK, Riojas RA. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 2006, 8:516-523.
36. Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, Testa JR. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 1999, 18:4891-4898.
37. Lin J, Wu H, Tarr PT. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
38. Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol 2003, 95:960-968.
39. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005, 1:361-370.
40. Patti ME, Butte AJ, Crunkhorn S. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003, 100:8466-8471.
41. Mootha VK, Lindgren CM, Eriksson KF. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
42. McAinch AJ, Lee JS, Bruce CR, Tunstall RJ, Hawley JA, Cameron-Smith D. Dietary regulation of fat oxidative gene expression in different skeletal muscle fiber types. Obes Res 2003, 11:1471-1479.